Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder

ClinicalTrials.gov ID: NCT03107026

Public ClinicalTrials.gov record NCT03107026. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-week, Randomized, Double-blind, Parallel-group, Placebo-controlled, Fixed-dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A study to evaluate a drug (dasotraline) on the safety, effectiveness and how well the body tolerates it, in adults with moderate to severe binge eating disorder

Study identification

NCT ID
NCT03107026
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
491 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2017 (Actual)
Primary completion
May 16, 2018 (Actual)
Completion
May 16, 2018 (Actual)
Last update posted
Jul 13, 2020

2017 – 2018

United States locations

U.S. sites
50
U.S. states
23
U.S. cities
47
Facility City State ZIP Site status
NoesisPharma, LLC Phoenix Arizona 85032 —
Southern California Research Beverly Hills California 90210 —
Pharmacology Research Institute Encino California 91316 —
Collaborative NeuroScience Network, LLC Garden Grove California 92845 —
Pharmacology Research Institute Newport Beach California 92660 —
PCSD- Feighner Research San Diego California 92108 —
Artemis Institute for Clinical Research San Marcos California 92708 —
Syrentis Clinical Research Santa Ana California 92705 —
MCB Clinical Research Centers, LLC Colorado Springs Colorado 80910 —
Lytle and Weiss PLLC Denver Colorado 80209 —
Connecticut Clinical Research Cromwell Connecticut 06416 —
Gulfcoast Clinical Research Center Fort Myers Florida 33912 —
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32256 —
Miami Research Associates South Miami Florida 33143 —
Institute for Advanced Medical Research at Mercer University Atlanta Georgia 30341 —
Neurotrials Research, Inc. Atlanta Georgia 30342 —
Northwest ehavioral Research Center Marietta Georgia 30060 —
Capstone Clinical Research Libertyville Illinois 60048 —
Phoenix Medical Research, Inc. Prairie Village Kansas 66208 —
Prairie Health and Wellness Wichita Kansas 67206 —
McLean Hospital Harvard Medical School Belmont Massachusetts 02478 —
Boston Clinical Trials Boston Massachusetts 02131 —
ActivMed Practices and Research, Inc Methuen Massachusetts 01844 —
Adams Clinical Trials, LLC Watertown Massachusetts 02472 —
Rocheser Center for Behavioral Medicine Rochester Hills Michigan 48307 —
Midwest Research Group - St. Charles Psychiatric Associates Saint Charles Missouri 63304 —
ActivMed Practice and Research, Inc Portsmouth New Hampshire 03801 —
Center for Emotional Fitness Cherry Hill New Jersey 08002 —
Bioscience Research, LLC Mount Kisco New York 10549 —
Manhattan Behavior Medicine New York New York 10036 —
The Medical Research Network, LLC New York New York 10128 —
Wake Research Associates Raleigh North Carolina 27612 —
Radient Research Akron Ohio 44311 —
Patient Priority Clinical Sites, LLC Cincinnati Ohio 45215 —
Midwest Clinical Research Center Dayton Ohio 45417 —
Linder Center of Hope Mason Ohio 45040 —
Oregon Center for Clinical Investigations, Inc. Portland Oregon 97214 —
Oregon Center for Clinical Investigations, Inc. Salem Oregon 97301 —
Lehigh Center for Clinical Research Allentown Pennsylvania 18104 —
Radiant Research Greer South Carolina 29650 —
Costal Carolina Research Center Mt. Pleasant South Carolina 29464 —
Clinical Neuroscience Solutions, Inc. Memphis Tennessee 38119 —
Clinical Research Associates, Inc Nashville Tennessee 37203 —
Donald J. Garcia, MD, PA Austin Texas 78737 —
Texas Center for Drug Development, Inc Houston Texas 77081 —
Pillar Clinical Research Richardson Texas 75080 —
Clinical Trials of Texas, Inc San Antonio Texas 78229 —
Radiant Research, Inc. San Antonio Texas 78229 —
Radiant Research, Inc. Murray Utah 84123 —
Neuropsychiatric Associates Woodstock Vermont 05091 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03107026, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 13, 2020 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03107026 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →